Viva Biotech Holdings (HK:1873) has released an update.
Viva Biotech Holdings has announced a voluntary initiative to buy back shares worth up to HK$100 million, based on the belief that the current market price undervalues the company’s intrinsic worth. This strategic move aims to enhance shareholder value and demonstrates the Board’s confidence in the firm’s long-term prospects. The buyback will be funded through internal resources and will comply with regulatory and legal standards.
For further insights into HK:1873 stock, check out TipRanks’ Stock Analysis page.
